These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Antihypertensive efficacy and tolerability of irbesartan/hydrochlorothiazide in hypertensive patients stratified by body mass index and type 2 diabetes mellitus status: a post hoc subgroup analysis of the Irbesartan/HCTZ Blood Pressure Reductions in Diverse Patient Populations trial. Lewin AJ, Weir MR. Clin Ther; 2008 Dec; 30(12):2354-65. PubMed ID: 19167594 [Abstract] [Full Text] [Related]
10. Comparison of Effectiveness of Azilsartan Medoxomil and Olmesartan in Blacks Versus Whites With Systemic Hypertension. Ferdinand KC, Bakris GL, Cushman WC, Weber MA, Lloyd E, Wu J, White WB. Am J Cardiol; 2018 Nov 01; 122(9):1496-1505. PubMed ID: 30217371 [Abstract] [Full Text] [Related]
16. [An open comparative study of captopril + hydrochlorothiazide versus chlorthalidone for the treatment of mild and moderate primary hypertension]. Franco RJ, Sampaio M, Balbi AL, Martin LC, Luna RL. Arq Bras Cardiol; 1992 Nov 01; 59(5):423-7. PubMed ID: 1340743 [Abstract] [Full Text] [Related]
19. Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure. Ernst ME, Carter BL, Goerdt CJ, Steffensmeier JJ, Phillips BB, Zimmerman MB, Bergus GR. Hypertension; 2006 Mar 01; 47(3):352-8. PubMed ID: 16432050 [Abstract] [Full Text] [Related]